Primary open angle glaucoma: an overview on medical therapy

Progress in Brain Research

Volumn 173, Issue , 2008, Pages 181-193

  Vetrugno, Michele ^a   Cantatore, Francesco ^a   Ruggeri, Giuseppe ^a   Ferreri, Paolo ^a   Montepara, Alfonso ^a   Quinto, Alessandra ^a   Sborgia, Carlo ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

glaucoma; medical therapy; prostaglandins; risk factors

Indexed keywords

ACECLIDINE; ACETYLCHOLINE; ADRENALIN; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; APRACLONIDINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAXOLOL; BIMATOPROST; BIMATOPROST PLUS TIMOLOL; BRIMONIDINE; BRINZOLAMIDE; CARBACHOL; CARBONATE DEHYDRATASE INHIBITOR; CARTEOLOL; CLONIDINE; DIPIVEFRINE; DORZOLAMIDE; DORZOLAMIDE PLUS TIMOLOL; LATANOPROST; LATANOPROST PLUS TIMOLOL; LEVOBUNOLOL; MIOTIC AGENT; PILOCARPINE; PINDOLOL; PROSTAGLANDIN DERIVATIVE; TIMOLOL; TIMOLOL MALEATE; TIMOLOL PLUS TRAVOPROST; TRAVOPROST;

AFRICAN AMERICAN; AGE DISTRIBUTION; AGRANULOCYTOSIS; ALLERGIC CONJUNCTIVITIS; ALLERGY; AMNESIA; BLINDNESS; BRONCHOSPASM; BURNING SENSATION; CATARACT; CLINICAL TRIAL; CONJUNCTIVA DISEASE; CONJUNCTIVAL HYPEREMIA; CONJUNCTIVITIS; COST BENEFIT ANALYSIS; DEPRESSION; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DROWSINESS; DRUG ABSORPTION; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ENTEROPATHY; ERYTHEMA; EXERCISE TOLERANCE; EYE DISCOMFORT; EYE DISEASE; FATIGUE; FLU LIKE SYNDROME; FUNCTION TEST; GASTROINTESTINAL SYMPTOM; GENETIC ASSOCIATION; HALLUCINATION; HEADACHE; HEART DISEASE; HUMAN; HYPERTRICHOSIS; HYPOTENSION; IMPOTENCE; INTRAOCULAR PRESSURE; INTRAOCULAR PRESSURE ABNORMALITY; IRIS DISEASE; LACRIMATION; LIBIDO; MALAISE; MOOD CHANGE; MUSCULOSKELETAL PAIN; NEPHROLITHIASIS; OPEN ANGLE GLAUCOMA; OPTIC NERVE; PARESTHESIA; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; PREVALENCE; PRIORITY JOURNAL; PRURITUS; RESPIRATION DEPRESSION; RESPIRATORY TRACT DISEASE; RETINA DETACHMENT; RETINA MACULA CYSTOID EDEMA; RETINA MACULA EDEMA; REVIEW; RISK FACTOR; SIDE EFFECT; SKIN PIGMENTATION; THROMBOCYTOPENIA; TONOMETRY; UPPER RESPIRATORY TRACT INFECTION; VISUAL ACUITY; VISUAL FIELD; WEIGHT REDUCTION; XEROSTOMIA;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; AGE FACTORS; CARBONIC ANHYDRASE INHIBITORS; DRUG COMBINATIONS; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; MIOTICS; OPHTHALMIC SOLUTIONS; PROSTAGLANDINS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS;

EID: 53049095943     PISSN: 00796123     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0079-6123(08)01113-8     Document Type: Review

References (22)

1. Barnebey H., Orengo-Nania S., Flowers B.E., Samples J., Mallick S., Landry T.A., and Bergamini M.V.W. The safety and efficacy of travoprost 0.004%/timolol 0.5% fixed combination ophthalmic solution. Am. J. Ophthalmol. 140 (2005) 1-7
2. Caprioli J., and Garway-Heath D.F. A critical reevaluation of current glaucoma management. Ophthalmology 114 11 Suppl. (2007) 1-41
3. European Glaucoma Society (2003). Terminology and guidelines for glaucoma, 2nd edn., Dogma Ed, Savona, Italy.
4. Fechtner R.D., and Realini T. Fixed combination of topical glaucoma medications. Curr. Opin. Ophthalmol. 15 (2004) 132-135
5. Goni F.J. 12-week study comparing the fixed combination of brimonidine and timolol with concomitant use of the individual components in patients with glaucoma and ocular hypertension. Eur. J. Ophthalmol. 15 5 (2005) 581-590
6. Gupta N., and Weinreb R.N. New definitions of glaucoma. Curr. Opin. Ophthalmol. 8 II (1997) 38-41
7. Hayreh S.S., Podhajsky P., and Zimmerman M.B. Beta-blocker eyedrops and nocturnal arterial hypotension. Am. J. Ophthalmol. 128 (1999) 301-309
8. Heijil A., Leske M.C., Bengtsson B., Hyman L., Bengtsson B., and Hussein M. Reduction of intraocular pressure and glaucoma progression : results from the Early Manifest Glaucoma Trial. Arch. Ophthalmol. 120 (2002) 1268-1279
9. Hommer A. A double masked, randomized, parallel comparison of a fixed combination of bimatoprost 0.03%/timolol 0.5% with non-fixed combination use in patients with glaucoma or ocular hypertension. Eur. J. Ophthalmol. 17 1 (2007) 53-62
10. Hughes B.A., Bacharach J., Craven E.R., Kabach M.B., Mallick S., Landry T.A., and Bergamini M.V.W. A three-month, multicenter, double-masked, study of the safety and efficacy of travoprost 0.004%/timolol 0.5% ophthalmic solution compared to travoprost 0.004% ophthalmic solution and timolol 0.5% dosed concomitantly in subjects with open-angle glaucoma or ocular hypertension. J. Glaucoma 14 5 (2005) 392-399
11. Hylton C., and Robin A.L. Update on prostaglandin analogs. Curr. Opin. Ophthalmol. 14 (2003) 65-69
12. Kass M.A., Heuer D.K., Higginbotham E.J., Johnson C.A., Keltner J.L., Miller J.P., Parrish R.K., Wilson M.R., and Gordon M.O. The ocular hypertension treatment study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch. Ophthalmol. 120 (2002) 701-713
13. Quigley H.A. Number of people with glaucoma worldwide. Br. J. Ophthalmol. 80 (1996) 389-393
14. Robin A.L. The role of alpha-agonists. Curr. Opin. Ophthalmol. 8 II (1997) 42-49
15. Schuman J.S., Katz G.J., Lewis R.A., Henry J.C., Mallick S., Wells D.T., Sullivan E.K., Landry T.A., Bergamini M.V.W., and Robertson S.M. Efficacy and safety of a fixed combination of travoprost 0.004%/timolol 0.5% ophthalmic solution once daily for open-angle glaucoma or ocular hypertension. Am. J. Ophthalmol. 140 (2005) 242-250
16. Schwarzt K., and Budenz D. Current management of glaucoma. Curr. Opin. Ophthalmol. 15 (2004) 119-126
17. Soltau J.B., and Zimmerman T.J. Changing paradigms in the medical treatment of glaucoma. Surv. Ophthalmol. 47 Suppl. 1 (2002) S2-S5
18. Talluto D., Wyse T.M., and Krupin T. Topical carbonic anhydrase inhibitors. Curr. Opin. Ophthalmol. 8 II (1997) 2-6
19. The European Glaucoma Prevention Study Group. Results of the European Glaucoma Prevention Study. Ophthalmology 112 (2005) 366-375
20. Tielsh J.M., Sommer A., Katz J., Royall R.M., Quigley H.A., and Javitt J. Racial variation in prevalence of POAG. JAMA 226 (1991) 369-374
21. Wilensky J.T. The role of diurnal pressure measurements in the management of open angle glaucoma. Curr. Opin. Ophthalmol. 15 (2004) 90-92
22. WuDunn D. Genetic basis of glaucoma. Curr. Opin. Ophthalmol. 13 (2002) 55-60